Senior Global Trial LeaderCSL Behring, Hessen, Germany
Disclosure information not submitted.
Phase 1 Study of the Safety and Pharmacokinetics of CSL889 (Hemopexin) in Adults with SCD
Saturday, June 8, 20249:00 AM – 9:15 AM ET